Accel Diagnostics, Llc
Dba Adx Diagnostic Lab

CAGE Code: 5G0E4

NCAGE Code: 5G0E4

Status: Active

Type: Commercial Supplier

Dun & Bradstreet (DUNS): 828862701

CAGE 5G0E4 Accel Diagnostics, Llc Dba Adx Diagnostic Lab
CAGE 5G0E4 Accel Diagnostics, Llc

Summary

Accel Diagnostics, Llc, Dba Adx Diagnostic Lab is an Active Commercial Supplier with the Cage Code 5G0E4 and is tracked by Dun & Bradstreet under DUNS Number 828862701..

Address

6009 Richmond Ave Ste 130
Houston TX 77057-6218
United States

Points of Contact

Accel Diagnostics, Llc http://www.acceldx.com/

Related Information

DUNS Report

Associated CAGE Codes People who viewed this 'CAGE Code' also viewed...

Mmlj Inc Abv Graphics Inc Tenneco Technology Services Inc Aquaterra Engineering Inc Yogurt Technologies Thoroughenvironmental Services Inc Amsi Intl Trading Corp System Integration And Installations Bmc Software, Inc. Alloy Chile Llc Rhdix Press Wyatt Inc Subsidiary Of U S Specialty Products And Insulation Co Quality Turbocharger Components Llc Omnispec Corp Harco Technologies Corp Integrated Command Software Inc Radx Corp Grinnell Fire Protection Argos Technologies, Inc.

CAGE Code FAQ Frequently Asked Questions (FAQ) for CAGE 5G0E4

What is CAGE Code 5G0E4?
5G0E4 is the unique identifier used by NATO Organizations to reference the physical entity known as Accel Diagnostics, Llc Dba Adx Diagnostic Lab located at 6009 Richmond Ave Ste 130, Houston TX 77057-6218, United States.
Who is CAGE Code 5G0E4?
5G0E4 refers to Accel Diagnostics, Llc Dba Adx Diagnostic Lab located at 6009 Richmond Ave Ste 130, Houston TX 77057-6218, United States.
Where is CAGE Code 5G0E4 Located?
CAGE Code 5G0E4 is located in Houston, TX, USA.

Contracting History for CAGE 5G0E4 Contracting History for CAGE 5G0E4 Most Recent 25 Records

75N92019C00002
Sbir Topic 97 - Phase Ii - Early Detection And Monitoring Of Cardiac Injury Due To Cardiotoxicity
14 Nov 2018
National Institutes Of Health Nhlbi
Department Of Health And Human Services (Hhs)
$727,427.00
75N92019C00002
Sbir Topic 97 - Phase Ii - Minimally Invasive Test For Chemotherapy-Induced Cardiotoxicity.
11 Aug 2023
National Institutes Of Health Nhlbi
Department Of Health And Human Services (Hhs)
$724,601.63
75N92019C00002
Sbir Topic 97 - Phase Ii - Minimally Invasive Test For Chemotherapy-Induced Cardiotoxicity
26 Feb 2020
National Institutes Of Health Nhlbi
Department Of Health And Human Services (Hhs)
$727,427.00
75N92019C00002
Sbir Topic 97 - Phase Ii - Minimally Invasive Test For Chemotherapy-Induced Cardiotoxicity
16 Nov 2020
National Institutes Of Health Nhlbi
Department Of Health And Human Services (Hhs)
$727,427.00